NUSAP1 promotes invasion and metastasis of prostate cancer

Catherine A. Gordon; Xue Gong; Durga Ganesh; James D. Brooks

doi:10.18632/oncotarget.15604

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

NUSAP1 promotes invasion and metastasis of prostate cancer

Catherine A. Gordon, Xue Gong, Durga Ganesh and James D. Brooks _

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2017; 8:29935-29950. https://doi.org/10.18632/oncotarget.15604

Metrics: PDF 2647 views | HTML 4276 views | ?

Abstract

Catherine A. Gordon1, Xue Gong1,2, Durga Ganesh1, James D. Brooks1,3

1Department of Urology, Stanford University School of Medicine, Stanford, CA, 94305, USA

2Department of Pathology, Stanford University School of Medicine, Stanford, CA, 94305, USA

3Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, 94305, USA

Correspondence to:

James D. Brooks, email: [email protected]

Keywords: NUSAP1, invasion, migration, metastasis, prostate cancer

Received: September 18, 2016 Accepted: January 25, 2017 Published: February 22, 2017

ABSTRACT

We have previously identified nucleolar and spindle associated protein 1 (NUSAP1) as a prognostic biomarker in early stage prostate cancer. To better understand the role of NUSAP1 in prostate cancer progression, we tested the effects of increased and decreased NUSAP1 expression in cell lines, in vivo models, and patient samples. NUSAP1 promotes invasion, migration, and metastasis, possibly by modulating family with sequence similarity 101 member B (FAM101B), a transforming growth factor beta 1 (TGFβ1) signaling effector involved in the epithelial to mesenchymal transition. Our findings provide insights into the importance of NUSAP1 in prostate cancer progression and provide a rationale for further study of NUSAP1 function, regulation, and clinical utility.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 15604

Publication Alerts

Post-Publication Promotion

Publication Discount

Research Papers:

NUSAP1 promotes invasion and metastasis of prostate cancer

Abstract